Cite
Stampfer SD, Goldwater MS, Bujarski S, et al. Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination. Clin Infect Pract. 2021;13:100130doi: 10.1016/j.clinpr.2021.100130.
Stampfer, S. D., Goldwater, M. S., Bujarski, S., Regidor, B., Zhang, W., Feinstein, A. J., Swift, R., Eshaghian, S., Vail, E., & Berenson, J. R. (2022). Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination. Clinical infection in practice, 13100130. https://doi.org/10.1016/j.clinpr.2021.100130
Stampfer, Samuel D, et al. "Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination." Clinical infection in practice vol. 13 (2022): 100130. doi: https://doi.org/10.1016/j.clinpr.2021.100130
Stampfer SD, Goldwater MS, Bujarski S, Regidor B, Zhang W, Feinstein AJ, Swift R, Eshaghian S, Vail E, Berenson JR. Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination. Clin Infect Pract. 2022 Jan;13:100130. doi: 10.1016/j.clinpr.2021.100130. Epub 2021 Dec 09. PMID: 34909634; PMCID: PMC8654462.
Copy
Download .nbib